Feedback

Browsing by S

Use an asterisk (*) for partial word searches (e.g. pemph*)

131 results found.

1.
Ordering Recommendation:  

Determine if the S (MNS3) antigen is expressed on the patient's red blood cells. To determine if the patient is heterozygous or homozygous for the S antigen, Little s Antigen Typing - Patient (2007721) should also be ordered.

2.
Ordering Recommendation:  

Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.

3.
Ordering Recommendation:  

Useful as a biomarker of various CNS pathologies and as a tumor marker for malignant melanoma.

4.
Ordering Recommendation:  

Test may be useful as a biomarker of various CNS pathologies.

5.
Ordering Recommendation:  

May be useful for the diagnosis of Crohn disease. Test by itself is not diagnostic and should be used in conjunction with other parameters to confirm disease. Inflammatory Bowel Disease Differentiation Panel (2013270) is the preferred test.

6.
Ordering Recommendation:  

Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.

7.
Ordering Recommendation:  

Aid in assessment of the etiology of anion gap acidosis.

8.
Ordering Recommendation:  

May be used to determine past exposure to S. typhii (eg, infection or vaccination) and S. paratyphi. This test cannot be used to confirm acute salmonellosis. If systemic symptoms of acute salmonellosis are present, the preferred tests are Stool Culture and E. coli Shiga-like Toxin by EIA (0060134) and Blood Culture (0060102) if typhoid fever is suspected.

9.
Ordering Recommendation:  

Aid in the diagnosis of schistosomiasis. Positive results in patients from endemic areas may not represent active infection.

10.
Ordering Recommendation:  

Aid in diagnosis of systemic scleroderma/sclerosis (SSc). Negative results do not rule out SSc. Preferred test is Comprehensive Systemic Sclerosis Panel (3000480).

11.
Ordering Recommendation:  

Determine if the Sd(a) (901012) antigen is expressed on the patient's red blood cells.

12.
Ordering Recommendation:  

Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.

13.
14.
Ordering Recommendation:  

Nonspecific test used to detect inflammation associated with infections, cancers, and autoimmune diseases.

15.
Ordering Recommendation:  

Use in assessment of tissue stores. For routine assessment of selenium deficiency or toxicity, the preferred test is Selenium, Urine (0025067).

16.
Ordering Recommendation:  

May be useful in the assessment of recent intake. For the assessment of deficiency or toxicity, Selenium, Urine (0025067) is preferred.

17.
Ordering Recommendation:  

Urine is the preferred specimen type for the assessment of selenium toxicity and deficiency. For the assessment of recent intake, Selenium, Serum or Plasma is available (0025023).

18.
19.
Ordering Recommendation:  

Aid in diagnosis of a sensory neuropathy when malignancy, other than plasma cell dyscrasia, is suspected.

20.
Ordering Recommendation:  

When used in conjunction with other autoantibody tests (ANCA, MPO), may assist in differentiating suspected Wegener granulomatosis (WG) from other vasculitides. May be useful when monitoring patients with PR-3 antibodies.
Panel tests are available. For the workup of suspected vasculitis, refer to ANCA-Associated Vasculitis Profile (ANCA/MPO/PR-3) with Reflex to ANCA Titer (2006480). For patients with a history of vasculitis, refer to Anti-Neutrophil Cytoplasmic Antibody with Reflex to Titer and MPO/PR-3 Antibodies (2002068).

21.
Ordering Recommendation:  

Gold standard test for diagnosis of heparin-induced thrombocytopenia (HIT).

22.
Ordering Recommendation:  

Preferred serotonin test when diagnosing carcinoid tumors is Serotonin, Whole Blood (0080395).

23.
Ordering Recommendation:  

Use to diagnose and monitor carcinoid tumors. Preferred serotonin test since most of the blood serotonin resides in the platelets.

24.
Ordering Recommendation:  

Optimize drug therapy and monitor patient adherence.

25.
26.
Ordering Recommendation:  

Preferred test for detecting Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis in variety of specimens.

27.
28.
Ordering Recommendation:  

Refer to Additional Technical Information document.

29.
30.
31.
32.
33.
34.
Ordering Recommendation:  

Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.

35.
Ordering Recommendation:  

Optimize drug therapy and monitor patient adherence.

36.
Ordering Recommendation:  

Determine a diagnosis in individuals with an undetermined skeletal dysplasia or determine the causative gene variant in affected adults prior to pregnancy.

37.
Ordering Recommendation:  

Prenatal diagnosis for suspected fetal skeletal dysplasia.

38.
Ordering Recommendation:  

Identify individuals at increased risk for statin-related muscle toxicity.

39.
Ordering Recommendation:  

Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.

40.
Ordering Recommendation:  

Confirmatory test for systemic lupus erythematosus (SLE) based on ANA results.

41.
Ordering Recommendation:  

Useful in confirming a diagnosis of systemic lupus erythematosus (SLE) or mixed connective tissue disease (MCTD) following a positive ANA result. Antibodies may be useful in the differential diagnosis of other systemic autoimmune rheumatic diseases such as systemic sclerosis, Sjögren syndrome, polymyositis, dermatomyositis, and overlap syndromes.

42.
Ordering Recommendation:  

Confirm a clinical or biochemical diagnosis of Smith-Lemli-Opitz syndrome(SLOS) or carrier screening for SLOS.

43.
Ordering Recommendation:  

Diagnostic fetal testing for pregnancies suspected to be affected with Smith-Lemli-Opitz syndrome (SLOS).

44.
Ordering Recommendation:  

Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.

45.
Ordering Recommendation:  

May be helpful in evaluating for autoimmune liver disease. For a more comprehensive reflex panel, refer to Autoimmune Liver Disease Evaluation with Reflex to Smooth Muscle Antibody (SMA), IgG by IFA (2007210).

46.
47.
Ordering Recommendation:  

Refer to aruplab.com/bodyfluids for clinical indications and interpretive information.

48.
49.
50.
Ordering Recommendation:  

Assess for targeted variants that are useful for prognosis and/or treatment of individuals with solid tumor cancers, including melanoma, gastrointestinal stromal tumor (GIST), colorectal, bladder, and hepatocellular carcinomas, at initial diagnosis or in the presence of refractory disease. If the clinical indication is lung cancer, additional molecular genetic testing may be considered for detection of gene rearrangements and/or c-MET exon 14-skipping alterations. For evaluation of microsatellite instability, additional molecular testing should be considered.

51.
Ordering Recommendation:  

Not recommended; order D-dimer test (0030057) instead.

52.
Ordering Recommendation:  

Recommended for the evaluation of autoimmune liver disease or hepatitis of unknown etiology.

53.
Ordering Recommendation:  

MESOMARK is FDA approved for use as a Humanitarian Use Device. IRB registration and certification is required prior to ordering.

54.
55.
56.
57.
58.
Ordering Recommendation:  

Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.

59.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

60.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

61.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

62.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

63.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

64.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

65.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

66.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

67.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

68.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

69.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

70.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

71.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

72.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

73.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

74.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

75.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

76.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

77.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

78.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

79.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

80.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

81.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

82.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

83.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

84.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

85.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

86.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

87.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

88.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

89.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

90.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

91.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

92.
93.
94.
Ordering Recommendation:  

Confirm a suspected diagnosis of spinal muscular atrophy (SMA) and quantify SMN2 copy number for treatment purposes in affected individuals. Use for prenatal or preconception carrier screening for SMA in the general population, carrier screening for the reproductive partner of a known SMA carrier, and carrier screening for parents of a child with a deletion of the SMN1 gene or other family history of SMA.

95.
Ordering Recommendation:  

Prenatal diagnostic testing for spinal muscular atrophy (SMA) when both parents carry a deletion of SMN1 or have a previous child with SMA caused by a deletion of SMN1.

96.
97.
Ordering Recommendation:  

Useful as a tumor marker for squamous cell carcinomas of the head and neck, uterine cervix, lung, vulva, and esophagus.

98.
Ordering Recommendation:  

Molecular diagnosis of synovial sarcoma.

99.
Ordering Recommendation:  

Order as secondary screen based on results of ANA test or if ANA IFA is negative and Sjögren syndrome, systemic lupus erythematosus (SLE), systemic sclerosis, or myositis is strongly suspected.

100.
Ordering Recommendation:  

Recommended for the differential diagnosis of SLE and Sjogren syndrome. Preferred panel contains SSA 52, SSA 60, and SSB; refer to Extractable Nuclear Antigen Antibodies (SSA 52, SSA 60, and SSB) (0050791).

101.
Ordering Recommendation:  

B-Type Natriuretic Peptide (0030191) or proBrain Natriuretic Peptide, NT (0050083) are preferred tests for diagnosis, prognosis, and management of acute and chronic heart failure. ST2 aids in prognostication in patients with acute and chronic heart failure.

102.
103.
Ordering Recommendation:  

Identify Staphylococcus aureus colonization.

104.
Ordering Recommendation:  

Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.

105.
Ordering Recommendation:  

Preferred test for suspected bacterial diarrhea evaluation. Testing includes cultures for Salmonella, Shigella, Campylobacter, E. coli O157, and EIA for Shiga-like toxin from E. coli. Can be used to rule out Aeromonas and Plesiomonas; specify the pathogen to rule out. For C. difficile testing, refer to Clostridium difficile toxin B gene (tcdB) by PCR (2002838).

106.
Ordering Recommendation:  

Identify presence of Campylobacter species in stool as potential cause of diarrhea with appropriate exposure history or risk factors.

107.
Ordering Recommendation:  

Diagnose Vibrio-associated diarrhea in patients with appropriate exposure history or risk factors.

108.
Ordering Recommendation:  

Diagnose Yersinia-associated diarrhea in patients with appropriate exposure history or risk factors.

109.
Ordering Recommendation:  

Gold standard for confirming group A streptococcal infection. Order when rapid testing is negative and suspicion of streptococcus is moderately high.

110.
111.
Ordering Recommendation:  

Determine genital and rectal Group B Streptococcus in pregnant women.

112.
Ordering Recommendation:  

Evaluate the ability of a patient to produce antibody to pure polysaccharide vaccines (Pneumovax) or protein conjugated vaccines (Prevnar).

113.
Ordering Recommendation:  

Evaluate the ability of a patient to produce antibody to pure polysaccharide vaccines (Pneumovax) or protein conjugated vaccines (Prevnar).

114.
Ordering Recommendation:  

Evaluate the ability of a patient to produce antibody to pure polysaccharide vaccines (Pneumovax) or protein conjugated vaccines (Prevnar).

115.
Ordering Recommendation:  

Aid in the diagnosis of pneumococcal meningitis.

116.
Ordering Recommendation:  

Aid in the diagnosis of pneumococcal pneumonia.

117.
Ordering Recommendation:  

Confirm a prior infection with group A Streptococcus in patients suspected of having a nonsuppurative complication such as acute glomerulonephritis (AGN) or acute rheumatic fever (ARF). DNase-B Antibody (0050220) and Streptolysin O Antibody (ASO) (0050095) antibody tests are generally ordered concurrently.

118.
Ordering Recommendation:  

Recommended for differential evaluation of neuromuscular junction diseases including myasthenia gravis (MG).

119.
Ordering Recommendation:  

Aid in the diagnosis of strongyloides. Positive results in patients from endemic areas may not represent active infection.

120.
121.
122.
Ordering Recommendation:  

For accurate quantitation of succinylacetone at diagnosis, organic acids recommended as initial or concurrent test. Monitor individuals with tyrosinemia type 1 who are on therapy. To rule out or diagnose tyrosinemia type 1, refer to Organic Acids, Urine (0098389) and Amino Acids Quantitative by LC-MS/MS, Plasma (2009389).

123.
Ordering Recommendation:  

Measurement of urinary sulfate excretion is used in calculi risk assessment.

124.
Ordering Recommendation:  

Non-panel testing for autoimmune neuropathies. Test by itself is not diagnostic and should be used in conjunction with other clinical parameters to confirm disease.

125.
126.
Ordering Recommendation:  

Optimize drug therapy and monitor patient adherence.

127.
Ordering Recommendation:  

Test may be useful in evaluating if etiology of hypoglycemia is from exposure to sulfonylurea hypoglycemic drugs. However, serum or plasma is the preferred specimen (refer to Hypoglycemia Panel, Sulfonylureas Qualitative, Serum or Plasma (2010292)).

128.
Ordering Recommendation:  

Use for kidney stone risk assessment and monitoring; includes interpretation of data. Panel includes calcium, chloride, citric acid, creatinine, magnesium, oxalate, pH, phosphorous, potassium, sodium, sulfate, and uric acid.

129.
Ordering Recommendation:  

Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.

130.
Ordering Recommendation:  

May be useful in the assessment of exposure to synthetic cannabinoids up to several days post-exposure.

131.